Endocrine Today expert interviews
Click Here to Manage Email Alerts
Each month Endocrine Today reporters ask leading endocrinologists and diabetes educators about their research and practices. Some of our recent Q&As are below.
New VITAL analyses shed light on vitamin D for bone health, fall prevention
Meryl Susan LeBoff, MD, chief of the calcium and bone section in the endocrinology, diabetes and hypertension division at Brigham and Women’s Hospital and professor of medicine at Harvard Medical School, spoke with Endocrine Today about the latest analyses to come out of the VITAL trial, what the findings mean for clinicians, and the importance of continuing to treat individuals with vitamin D deficiency.
As more children adopt diabetes technology, schools must share best practices
Anastasia Albanese-O’Neill, PhD, APRN, CDE, director of diabetes education and clinic operations in the division of pediatric endocrinology at the University of Florida, spoke with Endocrine Today about the diabetes technologies children are using and their benefits, as well as resources for schools serving these students.
Screen for fatty liver as a diabetes complication
Nonalcoholic fatty liver disease has surpassed alcoholism as a cause of cirrhosis and will soon be the primary cause of liver transplantation in the United States. Kenneth Cusi, MD, FACP, FACE, chief of the division of endocrinology, diabetes and metabolism at University of Florida, spoke with Endocrine Today about the pathophysiology, diagnosis and management of NASH ahead of the first symposium on the topic to be held during the American Diabetes Association Scientific Sessions.
NIH funding first artificial pancreas study in pregnant women
Carol Levy, MD, clinical director of the Mount Sinai Diabetes Center, is a principal investigator for a series of clinical trials testing the safety and efficacy of a closed-loop insulin delivery system adapted for pregnancy. She spoke with Endocrine Today about glucose management in pregnant women with diabetes, her own challenges living with type 1 diabetes and the unmet need for artificial pancreas technology in this patient population.
Researcher highlights new treatments for thyroid eye disease
Marius N. Stan, MD, an endocrinologist with Mayo Clinic in Rochester, Minnesota, spoke with Endocrine Today about some of the latest developments in thyroid eye disease research, including an experimental human monoclonal antibody shown to dramatically reduce the most debilitating symptoms of Graves’ orbitopathy, namely proptosis and double vision.